Global Initiative Launched to Distribute Mpox Vaccines to Vulnerable Populations

The World Health Organization (WHO) has initiated a program to distribute mpox vaccines, tests, and treatments to the most vulnerable people in the world's poorest countries. This move follows the approval of the first mpox vaccine and aims to prevent the spread of the virus from the Democratic Republic of Congo to neighboring countries. The program seeks to ensure equitable access to vaccines, with several high-income countries already committing donations.

On Friday, the World Health Organization (WHO) and its partners launched a significant initiative to deliver mpox vaccines, tests, and treatments to the world's most vulnerable populations, primarily in impoverished countries. This plan follows the approval of the first vaccine for the quickly spreading disease, helping African nations battle the virus that has extended from the Democratic Republic of Congo.

"Vaccines, therapeutics, and diagnostics are vital tools to control mpox outbreaks in Africa," stated WHO Director-General Tedros Adhanom Ghebreyesus. He emphasized that the COVID-19 pandemic highlighted the necessity for international cooperation to ensure fair access to medical resources. During the pandemic, many low-income nations were left behind in the chaotic global pursuit of vaccines.

European countries, the US, and Japan have pledged to donate 3.6 million doses of the two primary mpox vaccines, with vaccinations starting on Oct. 2. The WHO has encouraged more countries to donate smallpox vaccines stockpiled by wealthy nations and plans to collaborate with impacted countries to protect high-risk populations.

(With inputs from agencies.)